AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.
Recent Posts
- Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
- How much money you should save for a comfortable retirement
- Fed Governor Bowman says December interest rate cut should be the last
- IRS: Missing final 2024 quarterly estimated tax payment could trigger ‘unexpected penalties’
- Here’s a list of the top-rated charities to help the wildfire relief effort